For: | Castro-Neto EF, Cunha RHD, Silveira DXD, Yonamine M, Gouveia TLF, Cavalheiro EA, Amado D, Naffah-Mazzacoratti MDG. Changes in aminoacidergic and monoaminergic neurotransmission in the hippocampus and amygdala of rats after ayahuasca ingestion. World J Biol Chem 2013; 4(4): 141-147 [PMID: 24340137 DOI: 10.4331/wjbc.v4.i4.141] |
---|---|
URL: | https://www.wjgnet.com/1949-8454/full/v4/i4/141.htm |
Number | Citing Articles |
1 |
Cassandra J. Hatzipantelis, David E. Olson. The Effects of Psychedelics on Neuronal Physiology. Annual Review of Physiology 2024; 86(1) doi: 10.1146/annurev-physiol-042022-020923
|
2 |
Klemens Egger, Helena D. Aicher, Paul Cumming, Milan Scheidegger. Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-024-05353-6
|
3 |
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi, Michael Nader. Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. Pharmacological Reviews 2021; 73(1): 202 doi: 10.1124/pharmrev.120.000056
|
4 |
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi. Tasman’s Psychiatry. 2023; : 1 doi: 10.1007/978-3-030-42825-9_141-1
|
5 |
Giordano Novak Rossi, Lorena T. L. Guerra, Glen B. Baker, Serdar M. Dursun, José Carlos Bouso Saiz, Jaime E. C. Hallak, Rafael G. dos Santos. Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant. Biomolecules 2022; 12(11): 1618 doi: 10.3390/biom12111618
|
6 |
Rafael Naime Ruggiero, Danilo Benette Marques, Matheus Teixeira Rossignoli, Jana Batista De Ross, Tamiris Prizon, Ikaro Jesus Silva Beraldo, Lezio Soares Bueno-Junior, Ludmyla Kandratavicius, Jose Eduardo Peixoto-Santos, Cleiton Lopes-Aguiar, Joao Pereira Leite. Dysfunctional hippocampal-prefrontal network underlies a multidimensional neuropsychiatric phenotype following early-life seizure. eLife 2024; 12 doi: 10.7554/eLife.90997.3
|
7 |
Rafael G. dos Santos, Flávia L. Osório, José Alexandre S. Crippa, Jordi Riba, Antônio W. Zuardi, Jaime E. C. Hallak. Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology 2016; 6(3): 193 doi: 10.1177/2045125316638008
|
8 |
Antonio Inserra. Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00330
|
9 |
Thaina Maquedo Franco, Mariana R. Tavares, Leonardo S. Novaes, Carolina D. Munhoz, Jose Eduardo Peixoto-Santos, Ronaldo C. Araujo, Jose Donato, Michael Bader, Frederick Wasinski. Effects of Bradykinin B2 Receptor Ablation from Tyrosine Hydroxylase Cells on Behavioral and Motor Aspects in Male and Female Mice. International Journal of Molecular Sciences 2024; 25(3): 1490 doi: 10.3390/ijms25031490
|
10 |
Bruno Lobao-Soares, Paulianny Eduardo-da-Silva, Hugo Amarilha, Jaquelinne Pinheiro-da-Silva, Priscila F. Silva, Ana Carolina Luchiari. It’s Tea Time: Interference of Ayahuasca Brew on Discriminative Learning in Zebrafish. Frontiers in Behavioral Neuroscience 2018; 12 doi: 10.3389/fnbeh.2018.00190
|
11 |
Jonathan Hamill, Jaime Hallak, Serdar M. Dursun, Glen Baker. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness. Current Neuropharmacology 2019; 17(2): 108 doi: 10.2174/1570159X16666180125095902
|
12 |
Bruno Romeo, Marianne Hermand, Amélie Pétillion, Laurent Karila, Amine Benyamina. Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review. Journal of Psychiatric Research 2021; 137: 273 doi: 10.1016/j.jpsychires.2021.03.002
|
13 |
Dimitri Daldegan-Bueno, Natalia Maria Simionato, Vanessa Manchim Favaro, Lucas Oliveira Maia. The current state of ayahuasca research in animal models: A systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2023; 125: 110738 doi: 10.1016/j.pnpbp.2023.110738
|
14 |
Rafael Naime Ruggiero, Danilo Benette Marques, Matheus Teixeira Rossignoli, Jana Batista De Ross, Tamiris Prizon, Ikaro Jesus Silva Beraldo, Lezio Soares Bueno-Junior, Ludmyla Kandratavicius, Jose Eduardo Peixoto-Santos, Cleiton Lopes-Aguiar, Joao Pereira Leite. Dysfunctional hippocampal-prefrontal network underlies a multidimensional neuropsychiatric phenotype following early-life seizure. eLife 2024; 12 doi: 10.7554/eLife.90997
|
15 |
Andreia Machado Brito-da-Costa, Diana Dias-da-Silva, Nelson G. M. Gomes, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact. Pharmaceuticals 2020; 13(11): 334 doi: 10.3390/ph13110334
|
16 |
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi. Tasman’s Psychiatry. 2024; : 1 doi: 10.1007/978-3-030-42825-9_141-2
|
17 |
Daiane Momo Daneluz, Jeferson Machado Batista Sohn, Gabriela O. Silveira, Maurício Yonamine, Cristina Aparecida Stern. Evidence on the impairing effects of Ayahuasca on fear memory reconsolidation. Psychopharmacology 2022; doi: 10.1007/s00213-022-06217-2
|
18 |
Bianca Castro dos Santos, Ana Kéren Gomes Reis, Ricardo Aparecido Baptista Nucci, Ana Carolina Pinheiro Campos, Daniel de Oliveira Martins, Dimitri Daldegan-Bueno, Rosana Lima Pagano. The unpaved road of ayahuasca, a psychoactive brew, as a treatment for neuropathic pain: A review of mechanistic insights and clinical prospects. Brain Behavior and Immunity Integrative 2024; 8: 100087 doi: 10.1016/j.bbii.2024.100087
|
19 |
Vanessa Manchim Favaro, Maurício Yonamine, Juliana Carlota Kramer Soares, Maria Gabriela Menezes Oliveira, Yiwen Zheng. Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats. PLOS ONE 2015; 10(12): e0145840 doi: 10.1371/journal.pone.0145840
|
20 |
Edgar Antonio Estrella-Parra, Julio Cesar Almanza-Pérez, Francisco Javier Alarcón-Aguilar. Ayahuasca: Uses, Phytochemical and Biological Activities. Natural Products and Bioprospecting 2019; 9(4): 251 doi: 10.1007/s13659-019-0210-5
|
21 |
Cid Pinheiro Farias, Paula Pólvora Victoria, Janaína Xavier, Fernanda Gelati Sekine, Eduardo Silveira Ribeiro, Giana de Paula Cognato, Hudson Wander Carvalho. Behavioral characterization of ayahuasca treatment on Wistar rats in the open field test. Brazilian Journal of Pharmaceutical Sciences 2022; 58 doi: 10.1590/s2175-97902022e21110
|
22 |
Amanda A. Nunes, Rafael G. dos Santos, Flávia L. Osório, Rafael F. Sanches, José Alexandre S. Crippa, Jaime E. C. Hallak. Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans. Journal of Psychoactive Drugs 2016; 48(3): 195 doi: 10.1080/02791072.2016.1188225
|
23 |
Camila Schoueri Colaço, Stefany Sousa Alves, Luciana Marangni Nolli, Willie Oliveira Pinheiro, Danilo Gustavo Rodrigues de Oliveira, Beatriz Werneck Lopes Santos, Aline Pic-Taylor, Márcia Renata Mortari, Eloisa Dutra Caldas. Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats. Metabolic Brain Disease 2020; 35(5): 739 doi: 10.1007/s11011-020-00547-w
|
24 |
Beatriz Werneck Lopes Santos, Regina Célia de Oliveira, Julia Sonsin-Oliveira, Christopher William Fagg, José Beethoven Figueiredo Barbosa, Eloisa Dutra Caldas. Biodiversity of β-Carboline Profile of Banisteriopsis caapi and Ayahuasca, a Plant and a Brew with Neuropharmacological Potential. Plants 2020; 9(7): 870 doi: 10.3390/plants9070870
|
25 |
Pedro Santana Sales Lauria, Juliana de Medeiros Gomes, Lucas Silva Abreu, Rejane Conceição Santana, Victor Luiz Correia Nunes, Ricardo David Couto, Paulo Oliveira Colavolpe, Marcelo Sobral da Silva, Milena Botelho Pereira Soares, Cristiane Flora Villarreal. Ayahuasca and its major component harmine promote antinociceptive effects in mouse models of acute and chronic pain. Journal of Ethnopharmacology 2024; 323: 117710 doi: 10.1016/j.jep.2024.117710
|
26 |
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi. Tasman’s Psychiatry. 2024; : 4415 doi: 10.1007/978-3-030-51366-5_141
|
27 |
Eduardo Ekman Schenberg, Konstantin Gerber. Overcoming epistemic injustices in the biomedical study of ayahuasca: Towards ethical and sustainable regulation. Transcultural Psychiatry 2022; 59(5): 610 doi: 10.1177/13634615211062962
|
28 |
Dimitri Daldegan-Bueno, Vanessa Manchim Favaro, Paulo Rogério Morais, Alessandra Sussulini, Maria Gabriela Menezes Oliveira. Effects of repeated ayahuasca administration on behaviour and c-Fos expression in male rats exposed to the open field. Behavioural Brain Research 2022; 427: 113878 doi: 10.1016/j.bbr.2022.113878
|
29 |
Luciana Gueiros da Motta, Juliana Alves de Morais, Ana Carolina A.M. Tavares, Leonora Maciel Sousa Vianna, Marcia Renata Mortari, Rivadávio Fernandes Batista Amorim, Rosângela R. Carvalho, Francisco José R. Paumgartten, Aline Pic-Taylor, Eloisa Dutra Caldas. Maternal and developmental toxicity of the hallucinogenic plant-based beverage ayahuasca in rats. Reproductive Toxicology 2018; 77: 143 doi: 10.1016/j.reprotox.2018.03.002
|
30 |
N.F. Correa-Netto, M.Y. Masukawa, F. Nishide, G.S. Galfano, F. Tamura, M.K. Shimizo, M.P. Marcato, J.G. Santos Junior, A. Linardi. An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice. Brazilian Journal of Medical and Biological Research 2017; 50(7) doi: 10.1590/1414-431x20176036
|
31 |
Júlia Movilla Pires, Fúlvio Rieli Mendes, Ana Paula Salum Pires, Maurício Yonamine, José Luiz Gomes do Amaral, Elisaldo Araújo Carlini. Pre-clinical interaction of ayahuasca, a brew used in spiritual movements, with morphine and propofol. Brazilian Journal of Pharmaceutical Sciences 2018; 54(1) doi: 10.1590/s2175-97902018000117174
|
32 |
Amanda J. Khan, Ellen Bradley, Aoife O’Donovan, Joshua Woolley. Disruptive Psychopharmacology. Current Topics in Behavioral Neurosciences 2022; 56: 319 doi: 10.1007/7854_2022_366
|
33 |
Rafael G. dos Santos, Flávia L. Osório, José Alexandre S. Crippa, Jaime E.C. Hallak. Classical hallucinogens and neuroimaging: A systematic review of human studies. Neuroscience & Biobehavioral Reviews 2016; 71: 715 doi: 10.1016/j.neubiorev.2016.10.026
|
34 |
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, Josimar Hernandez Antonio, Philip A. Bonanno, Carolyn MacLeod, Charlotte Pierce, Hunter Carney, Morgan T. Morrison, Charles Saylor, George Danias, Lauren Lepow, Rachel Yehuda. The Psychedelic Future of Post-Traumatic Stress Disorder Treatment. Current Neuropharmacology 2024; 22(4): 636 doi: 10.2174/1570159X22666231027111147
|
35 |
Aline Pic-Taylor, Luciana Gueiros da Motta, Juliana Alves de Morais, Willian Melo Junior, Alana de Fátima Andrade Santos, Leandro Ambrósio Campos, Marcia Renata Mortari, Marcus Vinicius von Zuben, Eloisa Dutra Caldas. Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat. Behavioural Processes 2015; 118: 102 doi: 10.1016/j.beproc.2015.05.004
|
36 |
Samane Jahanabadi, Shayan Amiri, Mehdi Karkeh-abadi, Ali Razmi. Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters. Fitoterapia 2023; 169: 105620 doi: 10.1016/j.fitote.2023.105620
|